Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Weinhold

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Leukemia|July 4, 2014
Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myelomaN Weinhold, A Försti, M I da Silva Filho, et al.
Leukemia|March 19, 2011
Cost-effective multiplexing before capture allows screening of 25 000 clinically relevant SNPs in childhood acute lymphoblastic leukemiaA Wesolowska, M D Dalgaard, L Borst, et al.
Leukemia|August 10, 2021
Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugsJ R Jones, A Barber, Y-V Le Bihan, et al.
Leukemia|December 17, 2015
Genetic factors influencing the risk of multiple myeloma bone diseaseD C Johnson, N Weinhold, J Mitchell, et al.
Leukemia|December 21, 2011
Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortiumA Martino, D Campa, G Buda, et al.
Nature Communications|August 18, 2017
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencingL Rasche, S S Chavan, O W Stephens, et al.
Leukemia|December 22, 2018
Combination of flow cytometry and functional imaging for monitoring of residual disease in myelomaL Rasche, D Alapat, M Kumar, et al.
Leukemia|March 5, 2020
Correction: Role of growth arrest-specific gene 6-mer axis in multiple myelomaJ S Waizenegger, I Ben-Batalla, N Weinhold, et al.
Leukemia|August 9, 2014
Role of Growth arrest-specific gene 6-Mer axis in multiple myelomaJ S Waizenegger, I Ben-Batalla, N Weinhold, et al.
Bone Marrow Transplantation|May 16, 2017
Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trialS Huhn, N Weinhold, J Nickel, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Leukemia|July 4, 2014
Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myelomaN Weinhold, A Försti, M I da Silva Filho, et al.
Leukemia|March 19, 2011
Cost-effective multiplexing before capture allows screening of 25 000 clinically relevant SNPs in childhood acute lymphoblastic leukemiaA Wesolowska, M D Dalgaard, L Borst, et al.
Leukemia|August 10, 2021
Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugsJ R Jones, A Barber, Y-V Le Bihan, et al.
Leukemia|December 17, 2015
Genetic factors influencing the risk of multiple myeloma bone diseaseD C Johnson, N Weinhold, J Mitchell, et al.
Leukemia|December 21, 2011
Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortiumA Martino, D Campa, G Buda, et al.
Nature Communications|August 18, 2017
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencingL Rasche, S S Chavan, O W Stephens, et al.
Leukemia|December 22, 2018
Combination of flow cytometry and functional imaging for monitoring of residual disease in myelomaL Rasche, D Alapat, M Kumar, et al.
Leukemia|March 5, 2020
Correction: Role of growth arrest-specific gene 6-mer axis in multiple myelomaJ S Waizenegger, I Ben-Batalla, N Weinhold, et al.
Leukemia|August 9, 2014
Role of Growth arrest-specific gene 6-Mer axis in multiple myelomaJ S Waizenegger, I Ben-Batalla, N Weinhold, et al.
Bone Marrow Transplantation|May 16, 2017
Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trialS Huhn, N Weinhold, J Nickel, et al.
Pageof 3